Retinal Pigment Epithelium Safety Study for Patients in B4711001

Long Term, Open-Label, Safety Follow Up Study Following Transplantation of Pf-05206388 (Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)) in Subjects with Acute Wet Age Related Macular Degeneration and Recent Rapid Vision Decline

This is a safety follow-up study. Patients enrolled in B4711001 will be followed for a further 4 years with regular visits to assess safety.

Inclusion Criteria:

• Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study.
• Previous participation in Protocol B4711001 and received treatment with PF-05206388.
• Subjects who are willing and able to comply with scheduled visits, and study procedures.

Exclusion Criteria:

• there are no exclusion criteria